Creotech Instruments S.A. (WSE: CRI)
Poland
· Delayed Price · Currency is PLN 170.00
-0.50 (-0.29%)
Sep 27, 2024, 5:00 PM CET
Creotech Instruments Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Operating Revenue | 30.42 | 30.73 | 20.21 | 33.05 | 29.24 |
| Other Revenue | 11.92 | 13.32 | 13.36 | - | - |
| Revenue | 42.34 | 44.05 | 33.57 | 33.05 | 29.24 |
| Revenue Growth (YoY) | 18.40% | 31.21% | 1.59% | 13.04% | - |
| Cost of Revenue | 9.76 | 11.17 | 9.87 | 7.72 | 6.02 |
| Gross Profit | 32.58 | 32.88 | 23.7 | 25.33 | 23.22 |
| Selling, General & Admin | 40.8 | 39.93 | 26.05 | 30.48 | 24.04 |
| Other Operating Expenses | 2.09 | 1.8 | 1.74 | -6.71 | -4.54 |
| Operating Expenses | 51.28 | 49.97 | 32.43 | 25.88 | 21.02 |
| Operating Income | -18.7 | -17.1 | -8.73 | -0.55 | 2.2 |
| Interest Expense | -1.53 | -1.49 | -0.23 | -0.15 | -0.1 |
| Interest & Investment Income | 0.95 | 0.71 | 0.54 | 0 | 0 |
| Currency Exchange Gain (Loss) | 0.29 | 0.29 | 0.01 | -0.43 | 0.22 |
| Other Non Operating Income (Expenses) | -0.11 | -0.11 | -0.4 | -0.12 | -0.08 |
| EBT Excluding Unusual Items | -19.11 | -17.7 | -8.82 | -1.25 | 2.23 |
| Gain (Loss) on Sale of Assets | 0.23 | 0.23 | 0.04 | - | 0.01 |
| Asset Writedown | - | - | - | - | -0.02 |
| Other Unusual Items | - | - | - | 1.53 | 0.01 |
| Pretax Income | -18.88 | -17.47 | -8.78 | 0.28 | 2.23 |
| Income Tax Expense | -3.28 | -3.13 | -1.72 | -0.19 | 0.46 |
| Net Income | -15.6 | -14.34 | -7.06 | 0.47 | 1.78 |
| Net Income to Common | -15.6 | -14.34 | -7.06 | 0.47 | 1.78 |
| Net Income Growth | - | - | - | -73.25% | - |
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 1 |
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 1 |
| Shares Change (YoY) | 34.52% | 34.12% | 11.84% | 13.20% | - |
| EPS (Basic) | -6.55 | -6.03 | -3.98 | 0.30 | 1.27 |
| EPS (Diluted) | -6.55 | -6.03 | -3.98 | 0.30 | 1.27 |
| EPS Growth | - | - | - | -76.37% | - |
| Free Cash Flow | -24.73 | -7.14 | -19.14 | -19.5 | -7.55 |
| Free Cash Flow Per Share | -10.39 | -3.00 | -10.79 | -12.29 | -5.39 |
| Gross Margin | 76.94% | 74.64% | 70.59% | 76.64% | 79.42% |
| Operating Margin | -44.18% | -38.81% | -26.01% | -1.66% | 7.51% |
| Profit Margin | -36.84% | -32.56% | -21.04% | 1.44% | 6.07% |
| Free Cash Flow Margin | -58.40% | -16.21% | -57.01% | -59.01% | -25.84% |
| EBITDA | -15.61 | -14.15 | -6.87 | 1.55 | 3.72 |
| EBITDA Margin | -36.86% | -32.13% | -20.48% | 4.68% | 12.72% |
| D&A For EBITDA | 3.1 | 2.94 | 1.86 | 2.1 | 1.52 |
| EBIT | -18.7 | -17.1 | -8.73 | -0.55 | 2.2 |
| EBIT Margin | -44.18% | -38.81% | -26.01% | -1.66% | 7.51% |
| Effective Tax Rate | - | - | - | - | 20.50% |
| Revenue as Reported | 42.34 | 44.05 | 33.57 | 33.36 | 28.97 |
Source: S&P Capital IQ. Standard template. Financial Sources.